U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Tue Apr 01 16:31:58 GMT 2025
Edited
by admin
on Tue Apr 01 16:31:58 GMT 2025
Protein Type RECEPTOR
Protein Sub Type KINASE
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
1L68U00N7O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GP140TRK
Preferred Name English
HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR
Common Name English
TRK
Common Name English
MTC
Common Name English
TYROSINE KINASE RECEPTOR A
Common Name English
TROPOMYOSIN RECEPTOR KINASE A
Common Name English
NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1
Common Name English
TRKA
Common Name English
Code System Code Type Description
FDA UNII
1L68U00N7O
Created by admin on Tue Apr 01 16:31:58 GMT 2025 , Edited by admin on Tue Apr 01 16:31:58 GMT 2025
PRIMARY
PHAROS
P04629
Created by admin on Tue Apr 01 16:31:58 GMT 2025 , Edited by admin on Tue Apr 01 16:31:58 GMT 2025
PRIMARY
UNIPROT
P04629
Created by admin on Tue Apr 01 16:31:58 GMT 2025 , Edited by admin on Tue Apr 01 16:31:58 GMT 2025
PRIMARY
From To
1_122 1_159
1_183 1_233
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_35
N 1_63
N 1_89
N 1_156
N 1_170
N 1_221
N 1_230
N 1_249
N 1_286
N 1_291
N 1_306
N 1_326
N 1_369
Related Record Type Details
Structure of JNJ-28312141 FREE BASE
INHIBITOR -> TARGET
Structure of DANUSERTIB
INHIBITOR -> TARGET
CHF-6467
AGONIST -> TARGET
Mutation selectively disrupts the binding of hNGF to the p75NTR receptor while maintaining the affinity for the TrkA receptor. The R100 mutation abolishes the hyperalgesic effect that is usually associated with NGF without affecting most neurological functions.
NERVE GROWTH FACTOR
AGONIST -> TARGET
Mediates neuronal survival.
Structure of BMS-754807
INHIBITOR->OFF-TARGET
IC50
Structure of PF-06273340
INHIBITOR -> TARGET
Structure of LAROTRECTINIB
INHIBITOR -> TARGET
Active against NTRK gene fusions. Competitive to ATP binding site.
COMPETITIVE INHIBITOR
IC50
Structure of Boditrectinib
INHIBITOR -> TARGET
Structure of WRIGHTIADIONE
INHIBITOR -> TARGET
Structure of LPM-4870108
INHIBITOR -> TARGET
IC50
Structure of CH-7057288
INHIBITOR -> TARGET
IC50
Structure of BELIZATINIB
INHIBITOR -> TARGET
Structure of UDONITRECTAG
AGONIST -> TARGET
Structure of MILCICLIB
INHIBITOR -> TARGET
IC50
Structure of TRACK F-18
RADIOLIGAND->TARGET
Through a panel of 369 human kinases (no detectable kinase off-target at 1000-fold concentration over TrkB/C potency)
IC50
Structure of REPOTRECTINIB
INHIBITOR -> TARGET
Structure of ENTRECTINIB
INHIBITOR -> TARGET
Structure of CEP-751
INHIBITOR -> TARGET
IC50
Structure of TAVILERMIDE
AGONIST -> TARGET
Structure of ONO-7579
INHIBITOR -> TARGET
Structure of N-DESMETHYL ENTRECTINIB
INHIBITOR -> TARGET
IC50
Structure of TRACK
INHIBITOR -> TARGET
IC50
CENEGERMIN
AGONIST -> TARGET
Structure of GZ-389988
INHIBITOR -> TARGET
Structure of VMD-928
INHIBITOR -> TARGET
Structure of LESTAURTINIB
INHIBITOR -> TARGET
Structure of BPR-1K871
INHIBITOR -> TARGET

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID SUBSTITUTION [1_464] [1_644] [1_648] [1_649] [1_759] TYROSINE O-PHOSPHATE 2R86C98KDX
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966